Niger pioneers thermo-stable vaccine for Rotavirus- Aljazeera Report

ajaDoctors Without Borders (MSF) teams in Maradi, Niger are trialling a first-of-its-kind, thermo-stable vaccination for Rotavirus, a highly infectious disease that causes severe diarrhea and dehydration, killing an estimated 450 000 children around the world each year.

  • Rotavirus kills an estimated 450 000 children around the world
  • Existing vaccines must be kept below eight degrees celsius
  • New vaccine remains stable between 37-40°C
  • This is the first time a phase three vaccine trial of this kind has been approved in an African country

“Vaccines for Rotavirus do exist and the disease is completely preventable,” says Dr Stephen Nurse-Findlay, one of the hosts of Al Jazeera’s award-winning medical show, The Cure. “But these vaccines must be kept below eight degrees celsius, which makes it difficult to reach children in remote communities where resources are limited, and where the temperature can often soar.”

The cost of the new vaccine is also a lot cheaper than the existing vaccines. This means that more children can be treated, which, in turn, helps prevent the spread of the disease.

Nearly 8 000 children from across Maradi are participating in the trial. This is the first time a phase three vaccine trial of this kind has been approved in an African country.

In Niger’s Rotavirus, the second episode of the upcoming fifth season of The Cure, Nurse-Findlay travels to Maradi to find out more about this pioneering trial.

He discovers that traditionally the vaccine has been distributed in Niger using cooler boxes and thermometers, which has limited its efficiency to a 70km radius.

He speaks to Dr Amadou Matar, a medical investigator at Niger’s Epicentre research centre, who adds, “Electricity is not always reliable and the cold chain is really an obstacle.”

Matar also explains that Rotavirus is a problem with children under five in Niger “but children under two are the most seriously affected.”

“Although the trial for this new vaccine is ongoing, it seems to be proving effective,” says Nurse-Findlay, having witnessed its effects first-hand. “It’s hoped that the vaccine will be rolled out across other sub-Saharan countries by the end of this year. With Niger at the forefront of these developments, the impact of the work being done here could be enormous for children around the world.”

Niger’s Rotavirus premieres on Al Jazeera English on Monday, 27 June 2016 at 2330 West African Time / 2230 GMT.

About The Cure

Presented by practicing medics, The Cure takes you on a journey to the frontiers of world health, from cutting-edge scientific breakthroughs to advances in affordable healthcare for those who need it most. This series looks at some of the world’s most intractable health problems and the inspirational people working to find a cure. For more information, follow @ajcure on Twitter or visit

About Cholo Brooks 14593 Articles
Joel Cholo Brooks is a Liberian journalist who previously worked for several international news outlets including the BBC African Service. He is the CEO of the Global News Network which publishes two local weeklies, The Star and The GNN-Liberia Newspapers. He is a member of the Press Union Of Liberia (PUL) since 1986, and several other international organizations of journalists, and is currently contributing to the South Africa Broadcasting Corporation as Liberia Correspondent.